200,000+ products from a single source!
sales@angenechem.com
2637-37-8 | 2(1H)-Quinolinethione
CAS No: 2637-37-8 Catalog No: AG002SWR MDL No:MFCD00006751
Product Description
Catalog Number:
AG002SWR
Chemical Name:
2(1H)-Quinolinethione
CAS Number:
2637-37-8
Molecular Formula:
C9H7NS
Molecular Weight:
161.2236
MDL Number:
MFCD00006751
IUPAC Name:
1H-quinoline-2-thione
InChI:
InChI=1S/C9H7NS/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H,(H,10,11)
InChI Key:
KXZSVYHFYHTNBI-UHFFFAOYSA-N
SMILES:
S=c1ccc2c([nH]1)cccc2
EC Number:
220-132-4
UNII:
XW9BW0P3YZ
Properties
Complexity:
198
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
161.03g/mol
Formal Charge:
0
Heavy Atom Count:
11
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
161.222g/mol
Monoisotopic Mass:
161.03g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
44.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.9
Literature
| Title | Journal |
|---|---|
| Unique metabolic pathway of [(14)C]lenvatinib after oral administration to male cynomolgus monkey. | Drug metabolism and disposition: the biological fate of chemicals 20120401 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Decacarbonyl-1κC,2κC,3κC-μ-hydrido-1:2κH:H-(μ-quinoline-2-thiol-ato-1:2κS:S)diosmium(I)osmium(0)(3 Os-Os). | Acta crystallographica. Section E, Structure reports online 20080501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Quinoline-2(1H)-thione, a structure with Z' = 8. | Acta crystallographica. Section C, Crystal structure communications 20041201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.